Clinical Trial Detail

NCT ID NCT02632305
Title A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer (AX-CSARC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

cholangiocarcinoma

ampulla of Vater carcinoma

intrahepatic cholangiocarcinoma

gallbladder cancer

Therapies

Cisplatin + Gemcitabine + Nab-paclitaxel

Age Groups: adult senior

No variant requirements are available.